Tag: Herpes Simplex (Genital)
Global Incidence, Prevalence High for Genital Herpes Simplex Virus Infections
Number of people with at least one episode of HSV-attributable genital ulcer disease was 187.9 and 16.7 million for HSV-2, HSV-1 in 2020
Herpes Infections Recently Cost $35 Billion Globally
Authors urge acceleration of herpes simplex virus vaccination efforts
USPSTF Reaffirms Recommendation Against Genital Herpes Screening
Based on the evidence, the USPSTF continues to recommend against screening of asymptomatic adults and adolescents
Viral Shedding Common After First-Episode Genital HSV-1 Infection
Genital HSV-1 shedding often asymptomatic; genital lesions, oral lesions, and oral viral shedding less common
USPSTF Continues to Recommend Against Genital Herpes Screening
No new evidence identified to support changes to the 2016 recommendation against routine serologic screening for genital herpes
Increased Levels of Human Herpesvirus ID’d in Alzheimer’s
Disruption of molecular, genetic, clinical networks by human herpesvirus in brains of subjects with AD
HSV-1 Prevalence 47.8 Percent in 14- to 49-Year-Olds
Prevalence of herpes simplex virus type 2 is 11.9 percent; both declined from 1999-2000 to 2015-2016
Early Study Results Promising for Genital Herpes Vaccine
Two-pronged approach tested on lab monkeys, guinea pigs
Pritelivir Beats Valacyclovir for Genital HSV-2 Shedding
Phase 2 trial shows decline in relative risk of herpes simplex virus shedding over 28 days
USPSTF Recommends Against Routine HSV Screening
High proportion of false-positive results and associated psychological harms with screening
